1. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone;Branstetter;Clin. Cancer Res.,2012
2. Flanagan AM Larousserie F O'Donnell PG Yoshida A. Giant cell tumour of bone. In: Soft Tissue and Bone Tumours. WHO Classification of Tumours, 5th Edition, Volume 3 2020: 440-446. ISBN13 978-92-832-4502-5.
3. Forsyth RG, Krenács T, Athanasou N, Hogendoorn PCW. Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis. Cancers (Basel). Oct 13;13(20):5119. doi: 10.3390/cancers13205119.
4. Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013 Dec;45(12):1479-82. doi: 10.1038/ng.2814. Epub 2013 Oct 27. Erratum in: Nat Genet. 2014 Mar;46(3):316. Goodie, Victoria [corrected to Goody, Victoria].
5. Aberrant paracrine signalling for bone remodelling underlies the mutant histone-driven giant cell tumour of bone;Cottone;Cell Death Differ.,2022